Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Exagen XGN Rallies 802 as Bulls Target 396 20260519 Liberty FWONA Stock Slides 144 Support at 7797 20260517 MaxLinear Surges Nearly 300 on Trinity Platform Launch Catches Hedge Fund Attention What Steakholder STKHs 476 Decline Means for Investors 20260519 MCB Q1 2026 Earnings Solid Earnings Beat Highlights Resilient Core Performance Tesla Launches Full SelfDriving Supervised in China After Years of Delays as Local EV Makers Advance ConnectOne CNOB Q1 2026 Results A Closer Look at the Earnings Beat Eve Holding EVEX Q1 2026 Earnings Miss EPS 020 vs 017 Expected Monetarism Under Fire Critics Draw Parallels to Soviet Central Planning Shrinking Oil Inventories Raise Concerns Over Energy Supply Stability Nvidia Posts Record Earnings Yet Shares Dip on Growth Concerns IBMs Quantum Leap 27 Billion Market Cap Surge After Federal Quantum Computing Investment SpaceX OpenAI Could Surpass Berkshire Hathaway on First Trading Day Polymarket Shows Unity U and Meta META Strengthen LongTerm VR Platform Support and Enterprise Partnership NMFC Q1 2026 Earnings EPS Misses Estimates Slightly Stock Dips on Narrow Surprise REVB Q1 2026 Earnings Significant EPS Miss Amid EarlyStage Development Rio Tinto Q4 2025 Earnings EPS Falls Short of Expectations Despite Positive Stock Movement CPA Q1 2026 Earnings Strong EPS Surprise Despite Flat Stock Reaction Tredegar Corporation Q4 2025 Earnings Profitability Rises Despite Revenue Uncertainty BNB Plus Corp BNBX Q3 2025 Earnings Narrowed Loss Beats Expectations as Cost Controls Take Effect VYGR Q1 2026 Earnings Adjusted Loss Narrower Than Expected Despite No Revenue DHT Holdings Q1 2026 Earnings Strong EPS Beat Amid Tanker Market Strength Primerica PRI Q1 2026 Earnings EPS Surpasses Estimates by 77 Amid Mixed Market Reaction BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline AIM ImmunoTech Q1 2026 Earnings WiderthanExpected Loss on Absence of Revenue